Scryb -- ehemals Vervielfachungschance_ChroMedX (Seite 471)
eröffnet am 23.10.14 08:22:42 von
neuester Beitrag 04.05.24 13:56:23 von
neuester Beitrag 04.05.24 13:56:23 von
Beiträge: 12.084
ID: 1.201.093
ID: 1.201.093
Aufrufe heute: 34
Gesamt: 1.268.010
Gesamt: 1.268.010
Aktive User: 0
ISIN: CA81111V1076 · WKN: A3C86A · Symbol: EIY
0,0170
EUR
+6,25 %
+0,0010 EUR
Letzter Kurs 03.05.24 Tradegate
Werte aus der Branche Informationstechnologie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 1,0000 | +99.999,00 | |
| 0,5350 | +154,76 | |
| 0,5500 | +37,50 | |
| 0,5200 | +28,40 | |
| 2,4200 | +28,04 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 1,0400 | -25,18 | |
| 1,1100 | -32,52 | |
| 28,82 | -40,15 | |
| 5,0000 | -44,13 | |
| 7,8000 | -50,79 |
Beitrag zu dieser Diskussion schreiben
Feedback
On-site rapid COVID-19 testing for airport workers as part of research study
Note: Due to final regulatory approvals, employee tests will now be available for booking soon.
On-site COVID-19 testing will be available as part of a testing research study. The continued effort to prevent the spread of COVID-19 to workers, passengers and our surrounding communities, means we will be able to offer free, voluntary rapid COVID-19 testing on-site for airport workers and certain departing passengers.
The research study, supported in part by funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP), is designed to explore the effectiveness of antigen testing in a live environment, comparing it with the polymerase chain reaction (PCR) test. All airport workers will be able to participate, regardless of their role, employer or work location.
Information about testing for airport workers
Airport workers will be able to participate on a voluntary basis, regardless of their role, employer or work location.
Workers who have symptoms of COVID-19 will not be eligible for this study, and should contact their local public health unit for direction.
There will be no charge for COVID-19.
Pre-registration is required to access a test.
Learn more about the airport worker COVID-19 testing study and register for a test at torontopearson.com/testing.
Employee volunteers needed for additional frequent testing study
All airport workers are invited to volunteer for a frequent testing study, where participants are antigen tested three times weekly for an eight-week period.
In the Workplace Antigen Testing Study, the GTAA is partnering with university-affiliated epidemiologists to study the effectiveness of frequent antigen testing to help identify COVID-19 faster in the workplace. This study will produce scientific data that will help inform health and safety policies about potential future workplace testing, for the airport and similar environments.
To get involved in the frequent testing study:
Airport workers who volunteer will be tested 3 times per week for 8 weeks
Testing will happen at the soon to be launched Terminal 1 testing centre (public side)
All airport workers are eligible to participate in the study as long as they do not have symptoms of COVID-19
The antigen testing process takes about 10/15 minutes and results are expected within 15/30 minutes
Testing will be a nasal swab (lower nostril) and not a nasal pharyngeal swab (deep nasal) and will be administrated by a nurse
We are recruiting 500 airport workers to volunteer in the study
Testing appointments for the study will become available on March 8, 2021
Recruitment for the Workplace Antigen Study is happening now; employees can preregister to participate at torontopearson.com/workplacestudy.
Thank you to all interested employees for your contributions to further understanding of a science-based approach to COVID-19 testing protocols.
Note: Due to final regulatory approvals, employee tests will now be available for booking soon.
On-site COVID-19 testing will be available as part of a testing research study. The continued effort to prevent the spread of COVID-19 to workers, passengers and our surrounding communities, means we will be able to offer free, voluntary rapid COVID-19 testing on-site for airport workers and certain departing passengers.
The research study, supported in part by funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP), is designed to explore the effectiveness of antigen testing in a live environment, comparing it with the polymerase chain reaction (PCR) test. All airport workers will be able to participate, regardless of their role, employer or work location.
Information about testing for airport workers
Airport workers will be able to participate on a voluntary basis, regardless of their role, employer or work location.
Workers who have symptoms of COVID-19 will not be eligible for this study, and should contact their local public health unit for direction.
There will be no charge for COVID-19.
Pre-registration is required to access a test.
Learn more about the airport worker COVID-19 testing study and register for a test at torontopearson.com/testing.
Employee volunteers needed for additional frequent testing study
All airport workers are invited to volunteer for a frequent testing study, where participants are antigen tested three times weekly for an eight-week period.
In the Workplace Antigen Testing Study, the GTAA is partnering with university-affiliated epidemiologists to study the effectiveness of frequent antigen testing to help identify COVID-19 faster in the workplace. This study will produce scientific data that will help inform health and safety policies about potential future workplace testing, for the airport and similar environments.
To get involved in the frequent testing study:
Airport workers who volunteer will be tested 3 times per week for 8 weeks
Testing will happen at the soon to be launched Terminal 1 testing centre (public side)
All airport workers are eligible to participate in the study as long as they do not have symptoms of COVID-19
The antigen testing process takes about 10/15 minutes and results are expected within 15/30 minutes
Testing will be a nasal swab (lower nostril) and not a nasal pharyngeal swab (deep nasal) and will be administrated by a nurse
We are recruiting 500 airport workers to volunteer in the study
Testing appointments for the study will become available on March 8, 2021
Recruitment for the Workplace Antigen Study is happening now; employees can preregister to participate at torontopearson.com/workplacestudy.
Thank you to all interested employees for your contributions to further understanding of a science-based approach to COVID-19 testing protocols.
Antwort auf Beitrag Nr.: 67.304.979 von Toni666 am 04.03.21 14:18:04Zum Beispiel hier:
https://www.thecse.com/en/listings/life-sciences/relay-medic…
https://www.thecse.com/en/listings/life-sciences/relay-medic…
Wo finde ich dies Übersicht?
Die News gestern Nacht kam zuerst von IRW Press und nicht von Pollinger. Gutes Omen fùr heute Nachmittag😀👍
Trading Spotlight
Antwort auf Beitrag Nr.: 67.304.253 von JamaicaJack am 04.03.21 13:38:25auch in CAN kommen schöne bids rein.. 
Da steht in Frankfurt jetzt aber ein großes Paket von über 250.000 Stück in Bid 😎
In den letzten zwei Stunden sind dort auch ziemlich große Pakete (u.a. eins mit 100.0000 Stück) über den Tisch gegangen.
Bin auf die Holzfäller heute Nachmittag gespannt. 😉
In den letzten zwei Stunden sind dort auch ziemlich große Pakete (u.a. eins mit 100.0000 Stück) über den Tisch gegangen.
Bin auf die Holzfäller heute Nachmittag gespannt. 😉
Charttechnisch sieht es sehr viel versprechend aus. Es läuft kurzfristig in einer Dreiecke ein, was jeder Zeit nach oben ausbrechen und ein neues Kaufsignal generieren kann. Unter 0,5 Euro scheint es seit heute auch nicht mehr zu kriegen. Also einfach abwarten mit Geduld.
Sorry viele Schreibfehler wegen der Autokorrektur.
Also an einem Ende der Börseneuphorie glaube ich noch nicht. Daher daher sammle ich noch fleißig. Wenn die Abstimmung sich dreht, wird man guten Gewinn haben.
Durchsuchen
Scryb -- ehemals Vervielfachungschance_ChroMedX
